ALEXANDRIA, Va., April 21 -- United States Patent no. 12,607,639, issued on April 21.
"Diagnostic blood test for sarcoidosis" was invented by David R. Moller (Elicott City, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. The present invention discloses kits and a system for a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis."
The patent was filed on May 13, 2021, under Application No. 17/319,211.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=...